Professor
The University of Texas Southwestern Medical Center, Dallas
Dallas, Texas, United States
Philipp Scherer is Professor and Director of the Touchstone Diabetes Center and interim chair of the Department of Cell Biology at the University of Texas Southwestern Medical Center in Dallas. He received his Ph.D. degree from the University of Basel, Switzerland, with Jeff Schatz, followed by post-doctoral training the Whitehead Institute at MIT in Cambridge with Harvey Lodish.
Current efforts in his laboratory are focused on the identification and physiological characterization of novel proteins that serve as potential links between the adipocyte, liver, the pancreatic beta cell and the processes of whole body energy homeostasis, inflammation, cancer and cardiovascular disease. His research team aims to identify novel targets for pharmacological intervention and to further define the role of adipose tissue as an endocrine organ.
Scherer has been on the faculty of UT Southwestern Medical Center since 2007 as a member of the Departments of Internal Medicine and Cell Biology. He holds the Gifford O. Touchstone Jr. and Randolph G. Touchstone Distinguished Chair in Diabetes Research and is a member of the Simmons Comprehensive Cancer Center. He was awarded the 2015 Banting Medal for Scientific Achievement from the American Diabetes Association (the highest ranked diabetes prize in the world), the 2017 European Association for the Study of Diabetes Novo Nordisk Foundation Diabetes Prize for Excellence (the highest honor for a diabetes researcher in Europe), the 2018 Manpei Suzuki International Prize for Diabetes Research (highest honor in diabetes research in Japan), the 2019 Basic and Translational Science Award from the International Diabetes Federation (IDF) and the 2022 Society for Endocrinology Transatlantic Medal 2022 (United Kingdom).
Dr. Scherer has published more than 480 papers in the areas of diabetes, cardiovascular disease and obesity/cancer, has been cited more than 61,000 times and has an h-factor (Thompson-Reuters) of 123.
Disclosure information not submitted.
Saturday, November 5, 2022
12:00 PM – 1:30 PM ET
Saturday, November 5, 2022
12:00 PM – 1:30 PM ET